We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$150B
1-Year Est. Return
40.08%
This Fund
S&P 500
This Quarter
Est. Return
+22.49%
1 Year Est. Return
+40.08%
3 Year Est. Return
+113.08%
5 Year Est. Return
+141.06%
10 Year Est. Return
+565.41%
AUM
$150B
AUM Growth
+$18.9B
(+14%)
Cap. Flow
+$836M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
22.99%
Holding
2,421
New
260
Increased
1,156
Reduced
848
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$463M |
| 2 |
Apple
AAPL
|
+$418M |
| 3 |
SPCX
SpaceX
SPCX
|
+$361M |
| 4 |
NVIDIA
NVDA
|
+$291M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$428M |
| 2 |
Microsoft
MSFT
|
+$314M |
| 3 |
Boston Scientific
BSX
|
+$269M |
| 4 |
Teradyne
TER
|
+$249M |
| 5 |
T-Mobile US
TMUS
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.74% |
| 2 | Financials | 12.29% |
| 3 | Industrials | 12.09% |
| 4 | Healthcare | 8.91% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
CG Oncology
CGON
$6.62B
| $211K | ﹤0.01% |
+2,970
| New | +$194K |
|
|
SEM
2152
DELISTED
Select Medical
SEM
| $211K | ﹤0.01% |
12,762
-954
| -7% | -$15.7K |
|
2153
CBIZ
CBZ
$2.98B
| $210K | ﹤0.01% |
+6,558
| New | +$204K |
|
|
ORKA
2154
Oruka Therapeutics
ORKA
$6.13B
| $210K | ﹤0.01% |
+2,210
| New | +$147K |
|
2155
Insperity
NSP
$1.98B
| $210K | ﹤0.01% |
+5,081
| New | +$167K |
|
2156
Leonardo DRS
DRS
$9.77B
| $209K | ﹤0.01% |
4,908
+7
| +0.1% | +$311 |
|
|
BFS
2157
Saul Centers
BFS
$804M
| $209K | ﹤0.01% |
+5,596
| New | +$195K |
|
2158
Iovance Biotherapeutics
IOVA
$3.98B
| $209K | ﹤0.01% |
50,280
+3,621
| +8% | +$13.8K |
|
2159
Advance Auto Parts
AAP
$2.67B
| $209K | ﹤0.01% |
+3,352
| New | +$190K |
|
2160
Harmony Biosciences
HRMY
$2.46B
| $209K | ﹤0.01% |
+5,727
| New | +$181K |
|
2161
Centrus Energy
LEU
$3.47B
| $208K | ﹤0.01% |
+1,242
| New | +$232K |
|
2162
DNOW Inc
DNOW
$2.91B
| $208K | ﹤0.01% |
16,035
+3,824
| +31% | +$49.6K |
|
2163
Burford Capital
BUR
$955M
| $208K | ﹤0.01% |
50,711
+12,952
| +34% | +$59.2K |
|
2164
Vita Coco
COCO
$3.19B
| $207K | ﹤0.01% |
+3,137
| New | +$212K |
|
2165
Aurora
AUR
$12.7B
| $206K | ﹤0.01% |
30,171
-251
| -0.8% | -$1.53K |
|
2166
HubSpot
HUBS
$12.3B
| $205K | ﹤0.01% |
1,122
-720
| -39% | -$151K |
|
2167
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $205K | ﹤0.01% |
+3,440
| New | +$195K |
|
2168
Visteon
VC
$2.74B
| $204K | ﹤0.01% |
+2,060
| New | +$225K |
|
2169
Walker & Dunlop
WD
$1.46B
| $204K | ﹤0.01% |
+3,726
| New | +$189K |
|
|
GRAL
2170
GRAIL Inc
GRAL
$3.59B
| $203K | ﹤0.01% |
+2,976
| New | +$175K |
|
2171
National Bank Holdings
NBHC
$1.87B
| $203K | ﹤0.01% |
+4,570
| New | +$193K |
|
2172
Invesco Variable Rate Preferred ETF
VRP
$3.02B
| $203K | ﹤0.01% |
8,335
-800
| -9% | -$19.5K |
|
2173
Simply Good Foods
SMPL
$1.01B
| $203K | ﹤0.01% |
15,254
+4,049
| +36% | +$50K |
|
2174
Relay Therapeutics
RLAY
$4.17B
| $202K | ﹤0.01% |
10,822
+774
| +8% | +$11.2K |
|
2175
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.47B
| $202K | ﹤0.01% |
+2,945
| New | +$197K |
|
Similar funds
Neuberger Berman Group's Q2 2026 Portfolio in Review
As of Q2 2026, Neuberger Berman Group held 2,421 positions worth $150B, up 14% from $131B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Neuberger Berman Group's Q2 2026 filing shows 260 new, 1,156 increased, 848 reduced and 81 closed positions. Its largest new stake was SpaceX: 2,127,228 shares worth $363M. The largest sale was Advanced Micro Devices, an estimated $428M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Neuberger Berman Group's largest Q2 2026 buy was SpaceX: 2,127,228 shares worth $363M.
- Neuberger Berman Group added most to Amazon in Q2 2026, an estimated $463M increase.
- Neuberger Berman Group's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $428M.
- Neuberger Berman Group fully exited Hologic in Q2 2026, selling an estimated $103M.
- Neuberger Berman Group's ten largest holdings make up 23% of its $150B portfolio in Q2 2026.
- Neuberger Berman Group opened 260 new positions and closed 81 in Q2 2026.
- Neuberger Berman Group's portfolio value rose 14% quarter-over-quarter to $150B.
Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.